EANS-Adhoc: Semperit AG Holding Increases Revenue and Earnings in H1 2015

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Mid Year Results/6-month report
26.08.2015

- Good operational performance leads to organic growth - Better
performance of the Industrial Sector, weaker results of the Medical
Sector due to one-time effects - Satisfactory development expected
for the entire year 2015

The publicly listed Semperit Group generated a satisfactory revenue
and earnings development in the first half of 2015 despite a
challenging market environment. The group's consolidated revenue rose
by 1.6% to EUR 450.8 million from EUR 443.6 million in the previous
year. However, organic revenue growth reached 5.0% on a like-for-like
basis excluding one-time consolidation and acquisition effects.

Thanks to a strong sales performance and high capacity utilisation in
the Industrial Sector, Semperit managed to compensate the weaker
results in the Medical Sector attributable to one-time effects. The
net result (earnings after tax) increased by 0.3% to EUR 25.3 million
in the first half of 2015 (EUR 25.2 million in the first half of
2014). Earnings per share remained unchanged at EUR 1.23 for the
first half of 2015.

The group's EBITDA decreased by 16.7% to EUR 53.2 million from EUR
63.8 million in the previous year as a consequence of one-time
effects in the Medical Sector. EBIT declined by 11.4% to EUR 39.1
million (H1 2014: EUR 44.1 million). Accordingly, the EBITDA margin
dropped to 11.8% (H1 2014: 14.4%) and the EBIT margin was down to
8.7% (H1 2014: 9.9%). These declines can be attributed to the change
in the consolidation method of Semperit's joint venture in Thailand,
up-front costs for the new glove production plant in Malaysia and
lower raw material prices. On the other hand, the Industrial Sector
further increased earnings despite negative market trends.

"We achieved satisfactory results in the first half of 2015 despite
strong economic headwinds. Our Industrial Sector performed
considerably better than the overall market due to our strong sales
performance and expansion of production capacities. Profitability in
the Medical Sector was negatively impacted by up-front costs for the
new glove plant in Malaysia. It will start operating in 2016 and will
generate growth in revenue and earnings", Semperit CEO Thomas
Fahnemann comments on the company's results. "In the second half of
2015 - within a continuously difficult market environment - we expect
to benefit from additional production capacities, which will
gradually be available from September onwards. Furthermore, we will
expand into new markets and service new customer groups in the cause
of the integration of the German profile producer Leeser in the
Semperform segment", Thomas Fahnemann adds.

Semperit also performed well in the second quarter of 2015. Revenue
increased by 10.7% to EUR 233.4 million. EBITDA decreased by 8.8% to
EUR 28.4 million due to start-up costs for new production capacities,
EBIT fell by 7.1% to EUR 20.9 million. Despite these decreases,
profitability remained at a very good level as shown by an EBITDA
margin of 12.2% and an EBIT margin of 9.0%.

Semperit has a solid capital structure with an equity ratio of 39.1%
as of June 30, 2015 (53.7% as of December 31, 2014). Cash and cash
equivalents amounted to EUR 97.9 million compared to EUR 115.6
million at the end of 2014. This development mainly results from the
dividend payment. Semperit CFO Johannes Schmidt-Schultes: "With the
payment of a highly attractive dividend the restructuring of the
capital structure has been completed. We complemented equity with
debt at favourable conditions and still managed to maintain net debt
at a reasonable level. We are able to finance our growth activities
efficiently and create additional value on behalf of our
shareholders".

Medical Sector: One-time effects burden earnings The Medical Sector
(Sempermed segment) was negatively impacted by low raw material
prices, modernisation expenses and up-front costs for the new
production plant in Malaysia as well as price pressure on the markets
in the first half of 2015.

Revenue of the Medical Sector amounted to EUR 191.5 million in the
first half of 2015 (-4.2%) due to the change in the method of
consolidation. EBITDA of the Medical Sector decreased to EUR 13.7
million. This resulted in an EBITDA margin of 7.1% and an EBIT margin
of 4.0%. Revenue in the first half of 2015 increased by 6.3% on a
like-for-like basis excluding one-time effects related to the change
in the method of consolidation.

Industrial Sector: Growth despite negative market trends The
Industrial Sector (Semperflex, Sempertrans and Semperform segments)
developed very well despite negative market trends.

The Semperflex segment's outstanding production and sales performance
has been the basis for further revenue growth and high profitability
in an overall declining market. The recently added production
capacities at the plant in Odry, Czech Republic, have been well
utilised since the very beginning. Therefore the next expansion phase
is currently under way. The entry of Sempertrans to new markets and
the penetration of new customer segments led to substantial revenue
and earnings increases. Additional capacities in the conveyor belt
plant in Be?chatów, Poland will be put into operation at the end of
the third quarter of 2015. The Semperform segment achieved
double-digit revenue and earnings growth despite weaker demand in key
markets. This development is mainly resulting from the successful
acquisition of the profile producer Leeser and the beginning recovery
of the handrail business in China.

Revenue of the Industrial Sector rose by 6.4% to EUR 259.3 million.
The sector's EBITDA increased by 4.1% from a very high prior year
level to EUR 51.7 million. The EBITDA margin was 19.9%, whereas the
EBIT margin rose to 17.0%.

Outlook 2015 and multi-year targets Semperit continues to have strong
order books as a result of intensified sales activities in all
segments. Despite a slightly weaker than expected economic recovery
in Western Europe, order intake develops well. The market continues
to develop stable in North America. There is a slight recovery in
Central and Eastern Europe recognisable - with the exception of
Russia and the Ukraine. The development in Asia is expected to remain
difficult in 2015.

The Semperit Group anticipates a satisfactory business performance
for the year 2015 despite an ongoing challenging business
environment. Revenue and earnings should again be at an attractive
level, although from today's perspective the company is unlikely to
reach the earnings performance of the previous year. This is due to
the more difficult market environment, effects related to the change
in the method of consolidation of the joint venture in Thailand and
up-front costs for additional production capacities as well as
efficiency enhancement projects, which will positively impact
Semperit's earnings situation in subsequent years.

Semperit is still committed to qualitative and profitable growth in
the Medical Sector. Therefore the focus in 2015 is on efficiency
improvements at the individual production sites, the expansion of
high-margin customer relationships and the continuation of the
expansion of capacity in Kamunting, Malaysia. The successful sales
drive in the Industrial Sector will be continued.

Semperit is continuing the expansion of production capacities in both
the Medical Sector and Industrial Sector. Capital expenditure (CAPEX)
of approximately EUR 75 million is planned for 2015 (2014: EUR 74
million), of which EUR 50 million relate to growth investments. The
additional capacities will gradually be available in the course of
the years 2015 and 2016 with correspondingly positive effects on the
group's revenue.

In the future, Semperit is striving to achieve double-digit growth of
sales volumes on average as well as attractive earnings margins. For
the time being, Semperit confirms the targeted EBITDA margin between
12% and 15% and an EBIT margin between 8% and 11%.

Note: Figures for the first half of 2014 were adjusted (comparison
with prior year periods is only of limited informative value due to
the change in the method of consolidation of the joint venture
company in Thailand as of March 31, 2014).

The report is available for download at:
http://www.semperitgroup.com/en/ir --> Reports and Presentations.

About Semperit The publicly listed company Semperit AG Holding is an
internationally-oriented group that develops, produces, and sells in
more than 100 countries highly specialised rubber and plastic
products for the medical and industrial sectors: examination and
surgical gloves, hydraulic and industrial hoses, conveyor belts,
escalator handrails, construction profiles, cable car rings, and
products for railway superstructures. The headquarters of this
long-standing Austrian company, which was founded in 1824, are
located in Vienna. The Semperit Group employs about 7,000 people
worldwide, including close to 4,100 in Asia and more than 800 in
Austria (Vienna and production site in Wimpassing, Lower Austria).
The group has 22 manufacturing facilities worldwide and numerous
sales offices in Europe, Asia, and America. In 2014 the group
generated sales of EUR 858 million and an EBITDA of EUR 102 million.

Further inquiry note:
Martina Büchele
Group Head of Communications
Tel.: +43 676 8715 8621
martina.buechele@semperitgroup.com
www.semperitgroup.com

Stefan Marin
Investor Relations
Tel.: +43 676 8715 8210
stefan.marin@semperitgroup.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer: Semperit AG Holding
Modecenterstrasse 22
A-1030 Wien
phone: +43 1 79 777-210
FAX: +43 1 79 777-602
mail: investor@semperitgroup.com
WWW: www.semperitgroup.com
sector: Synthetics & Plastics
ISIN: AT0000785555
indexes: WBI, ATX Prime, ViDX, Prime Market, ATX Global Players
stockmarkets: official market: Wien
language: English